MacroGenics | MGNX - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.67B 140M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Genmab DKK 2.8B 228M 2026-06
Geron USD 486.34M 12.19M 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 36.68B 1.66B 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Xencor USD 523.21M 40.36M 2026-06